Mylan Pharmaceuticals Inc. v. Bausch Health Ireland Ltd.

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
MYLAN PHARMACEUTICALS INC.,
Appellant
v.
BAUSCH HEALTH IRELAND LTD.,
Appellee
______________________
2024-1011
______________________
Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in Nos. IPR2022-
00722, IPR2023-00016.
--------------------------------------------------
MSN LABORATORIES PRIVATE LTD., MSN
PHARMACEUTICALS, INC.,
Appellants
v.
BAUSCH HEALTH IRELAND LTD.,
Appellee
______________________
2024-1053
______________________
Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in Nos. IPR2022-
00722, IPR2023-00016.
Case: 24-1011 Document: 55 Page: 1 Filed: 05/19/2025

-- 1 of 2 --

MYLAN PHARMACEUTICALS INC. v.
BAUSCH HEALTH IRELAND LTD.
2
______________________
ON STIPULATION
______________________
P ER CURIAM .
O R D E R
Mylan Pharmaceuticals Inc. and Bausch Health Ire-
land Ltd stipulate to voluntary dismissal of Appeal No. 24-
1011.
The parties, having so agreed,
I T I S O RDERED T HAT :
(1) Appeal No. 24-1011 is dismissed under Fed. R.
App. P. 42(b), with each side to bear their own costs.
(2) The official captions as modified, are reflected in
this order.
May 19, 2025
Date
F OR THE COURT
ISSUED AS A MANDATE (as to Appeal No. 24-1011
only): May 19, 2025.
Case: 24-1011 Document: 55 Page: 2 Filed: 05/19/2025

-- 2 of 2 --